Global Retractable Prefillable Syringes Market Size By Type (Plastic, Glass), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Retractable Prefillable Syringes Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 5.1 billion by 2031, growing at a CAGR of 9.8% during the forecast period of 2023–2031. This growth is fueled by the increasing demand for safety-engineered injection systems, rising incidence of needlestick injuries, and growing preference for single-dose drug delivery formats. Retractable prefillable syringes combine safety features with ease of use, making them increasingly favored for vaccine administration, chronic disease management, and emergency medical use. They also reduce the risk of contamination and improve dosing accuracy, supporting global public health initiatives.

Drivers:

1. Increasing Focus on Needlestick Injury Prevention:

Healthcare regulations across developed and emerging markets are enforcing safer syringe systems, making retractable prefillable syringes a preferred solution due to their automated needle retraction mechanism that minimizes the risk of accidental injuries.

2. Rising Adoption of Prefilled Syringes in Biologics Delivery:

With the expanding biologics and biosimilars market, pharmaceutical companies are adopting prefilled syringe formats to improve drug stability and patient compliance, significantly boosting the demand for retractable variants.

3. Growth in Vaccination Programs:

Global immunization drives, including COVID-19 and flu vaccinations, have accelerated the need for safe, efficient, and easy-to-use delivery mechanisms, with retractable prefillable syringes emerging as a top choice among healthcare providers.

Restraints:

1. High Manufacturing Costs:

The complex design and advanced engineering involved in retractable syringe systems contribute to higher production costs compared to conventional prefillable syringes, posing a barrier for mass adoption in cost-sensitive markets.

2. Limited Awareness in Developing Regions:

In some lower-income countries, limited knowledge among healthcare professionals about retractable syringe benefits and availability may hinder their broader acceptance.

Opportunity:

1. Regulatory Push for Safer Injection Systems:

Government initiatives and WHO recommendations on safe injection practices are fostering significant opportunities for market players to expand with innovative retractable syringe technologies.

2. Expansion in Home Healthcare and Self-Injection Trends:

The rise in self-administered treatments for chronic conditions such as diabetes and rheumatoid arthritis is opening new avenues for retractable prefillable syringe adoption in the homecare setting.

Market by System Type Insights:

Based on system type, the Manual Retractable Prefillable Syringes segment dominated the market in 2023, accounting for the largest revenue share. These syringes offer reliability and simplicity, especially in mass immunization drives and outpatient care. However, the Automatic Retractable Prefillable Syringes segment is anticipated to grow at the fastest pace during the forecast period, driven by technological innovations that enhance user safety and reduce procedural steps.

Market by End-use Insights:

The Hospitals & Clinics segment led the market in 2023, supported by high patient volumes and the widespread use of injectable drugs. Additionally, the Homecare segment is expected to witness robust growth, propelled by rising chronic disease prevalence and patient preference for self-administration supported by easy-to-use retractable designs.

Market by Regional Insights:

North America held the largest market share in 2023, owing to stringent regulatory frameworks, high healthcare expenditure, and early adoption of safety-engineered devices. Asia-Pacific is projected to be the fastest-growing region during the forecast period, driven by rising healthcare investments, expanding pharmaceutical manufacturing, and government-supported vaccination programs in countries like China and India.

Competitive Scenario:

Key players in the Global Retractable Prefillable Syringes Market include:

BD (Becton, Dickinson and Company)

Gerresheimer AG

SCHOTT AG

West Pharmaceutical Services, Inc.

Retractable Technologies, Inc.

Nipro Corporation

Terumo Corporation

Stevanato Group

Owen Mumford Ltd.

Elcam Medical

These companies are emphasizing innovation, partnerships with pharmaceutical manufacturers, and regional expansion. For example:

In 2024, BD launched a next-gen retractable prefillable syringe platform with an enhanced safety-locking mechanism.

Retractable Technologies partnered with a global vaccine distributor in 2023 to supply retractable syringes for large-scale immunization campaigns.

Gerresheimer expanded its manufacturing capacity in Asia-Pacific in 2025 to meet growing demand for sterile injectable packaging.

Scope of Work – Global Retractable Prefillable Syringes Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 5.1 billion

CAGR (2023–2031) 9.8%

Market Segments By System Type, By End-use, By Region

Growth Drivers Needlestick injury prevention, biologics demand, immunization efforts

Opportunities Homecare expansion, regulatory safety mandates

Key Market Developments:

May 2024: BD launched the Integra™ SafeFill retractable prefilled syringe platform to support large-scale immunization in resource-limited settings.

September 2023: West Pharmaceutical announced the integration of RFID tracking in retractable prefillable syringes to improve supply chain monitoring.

February 2025: Gerresheimer AG unveiled a fully automated retractable syringe assembly line in India to cater to the growing regional demand.

FAQs:

1) What is the current market size of the Global Retractable Prefillable Syringes Market?

The market was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global Retractable Prefillable Syringes Market?

The key growth driver is the increasing demand for safety-engineered injection systems to prevent needlestick injuries.

3) Which is the largest region during the forecast period in the Global Retractable Prefillable Syringes Market?

North America is the largest region in terms of market share, while Asia-Pacific is the fastest-growing.

4) Which segment accounted for the largest market share in the Global Retractable Prefillable Syringes Market?

The Manual Retractable Prefillable Syringes segment held the largest market share in 2023.

5) Who are the key market players in the Global Retractable Prefillable Syringes Market?

Major players include BD, Gerresheimer AG, West Pharmaceutical Services, Terumo Corporation, and Retractable Technologies, Inc.

Would you like this report as a downloadable PDF or Word document?